Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-08-09 4 B $5.88 $4,341,386 I/I 738,331 738,331 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-17 4 B $5.98 $251,160 I/I 42,000 285,964 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-09-30 4 A $5.99 $1,000,162 I/I 164,134 2,762,970 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-19 4 B $6.02 $360,598 I/I 59,900 382,691 2.25 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-01-31 4 A $6.02 $200,002 I/I 33,223 18,528,842 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-03-20 4 B $6.06 $7,704,901 I/I 1,264,657 6,328,853 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-08-10 4 B $6.13 $1,604,031 I/I 261,669 1,000,000 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-12-11 4 B $6.16 $492,800 I/I 80,000 1,262,000 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-12-31 4 A $6.54 $999,993 I/I 127,082 16,043,868 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-08-30 4 A $6.65 $1,000,282 I/I 137,353 2,632,209 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-15 4 B $7.35 $3,142,720 I/I 427,581 3,333,528 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-04 4 B $7.37 $660,691 I/I 89,646 328,663 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-01 4 B $7.39 $732,201 I/I 99,080 283,840 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-16 4 B $7.44 $2,566,130 I/I 344,910 3,678,438 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-05 4 B $7.48 $40,863 I/I 5,463 331,394 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-17 4 B $7.50 $2,242,553 I/I 299,007 3,977,445 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-01-31 4 A $7.66 $199,995 I/I 26,109 16,083,751 0 -
PGEN Precigen Inc Director   –       •       •   2021-03-25 4 A $7.71 $99,999 I/I 12,970 18,329,996 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-07-31 4 A $7.76 $1,000,227 I/I 128,235 2,524,944 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2007-03-14 4 B $7.91 $238,882 I/I 30,200 522,460 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2007-03-13 4 B $7.93 $365,414 I/I 46,080 1,308,080 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-02-28 4 A $7.97 $199,999 I/I 25,094 16,108,845 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-23 4 B $8.00 $1,328,800 I/I 166,100 1,915,947 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-21 4 B $8.04 $454,075 I/I 56,477 1,694,701 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-22 4 B $8.11 $447,234 I/I 55,146 1,749,847 2.25 -
  271  Records found
  1   2   3   4   5   6   7  8   9   10   11      
  Page 7 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us